Evidence map›Paper›PMID 41593184›Full record

ArticleScientific reports2026

CDS-PD: a novel clinical decision support platform for Parkinson's disease.

Deepak K Gupta, Pedram Golnari, Katrina Prantzalos, Ian Zurlo, Vivikta Iyer, Brenna M Lobb, Cole Zweber, Manu Bulusu, Dakota Clarke, James T Boyd and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Deepak K GuptaDepartment of Neurology, University of Vermont Medical Center, Burlington, VT, USA. drdkgupta@gmail.com.
Pedram GolnariDepartment of Population & Quantitative Health Sciences, School of Medicine, Case Western Reserve University, Cleveland, OH, USA.
Katrina PrantzalosDepartment of Population & Quantitative Health Sciences, School of Medicine, Case Western Reserve University, Cleveland, OH, USA.
Ian ZurloDepartment of Neurology, University of Vermont Medical Center, Burlington, VT, USA.
Vivikta IyerDepartment of Neurology, University of Vermont Medical Center, Burlington, VT, USA.
Brenna M LobbParkinson's Disease Research Education and Clinical Center (PADRECC), VA Health Care System, Portland, Portland, OR, USA.
Cole ZweberDepartment of Neurology, University of Vermont Medical Center, Burlington, VT, USA.
Manu BulusuDepartment of Population & Quantitative Health Sciences, School of Medicine, Case Western Reserve University, Cleveland, OH, USA.
Dakota ClarkeParkinson's Disease Research Education and Clinical Center (PADRECC), VA Health Care System, Portland, Portland, OR, USA.
James T BoydDepartment of Neurology, University of Vermont Medical Center, Burlington, VT, USA.
Curtis TatsuokaUniversity of Maryland Marlene & Stewart Greenebaum Comprehensive Cancer Center Biostatistics Shared Resource Center, Baltimore, MD, USA.
Amie L HillerParkinson's Disease Research Education and Clinical Center (PADRECC), VA Health Care System, Portland, Portland, OR, USA.
Satya S SahooDepartment of Population & Quantitative Health Sciences, School of Medicine, Case Western Reserve University, Cleveland, OH, USA. satya.sahoo@case.edu.

Funding

U.S. Department of Defense W81XWH2110859
6 · The paper itself

Abstract

The Movement Disorders Society clinical diagnostic criteria for Parkinson's disease (MDS-PD) allow highly sensitive and specific diagnosis of Parkinson's disease. However, their adoption has been limited due to lack of a clinical decision support (CDS) tool to support clinicians and researchers in systematically and accurately applying the MDS-PD criteria. We have developed and performed preliminary validation of a CDS platform for PD (CDS-PD) as a modular and extensible informatics platform with comprehensive functionalities for recording relevant patient information. We have performed real-time application of diagnostic algorithm of the MDS-PD criteria. The CDS-PD platform shows high concordance with application of the MDS-PD criteria by experienced movement disorders neurologists for established PD (disease duration ≥ 5 years). The CDS-PD platform is a step towards realizing the standardized electronic implementation of the MDS-PD criteria for PD patient care and clinical trials at point-of-care. The CDS-PD platform can be accessed after registration at weblink https://www.cdspd.org .

Indexed as

Decision Support Systems, ClinicalParkinson DiseaseAlgorithmsHumansDiagnosisInformaticsParkinson’s disease

Identifiers

PMID41593184
PMCPMC12909838

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.